Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

People In Brief

This article was originally published in The Gray Sheet

Executive Summary

Rita Medical: Fremont, Calif. company engages executive search firm Stuart Spencer to assist in recruiting new CFO to replace outgoing exec Donald Stewart, who plans to resign as soon as a suitable substitute is found. Stewart served as Rita's interim CEO during 2003 and was a senior member of the firm's integration team during its merger with Horizon Medical Products last year (1"The Gray Sheet" May 17, 2004, p. 21). Rita sells radiofrequency ablation systems using disposable needles under the Starburst brand and vascular access devices including the Vortex ports...

You may also be interested in...



People In Brief

NovoStent gets new CEO: Ray Martin, PhD, will replace the firm's founder and primary inventor, Michael Hogendijk, as President & CEO. Hogendijk will continue as chief technical officer. Martin was most recently VP-business development of TriVascular, which was acquired by Boston Scientific in April. He also has held executive positions at Bard and W.L. Gore, where he co-invented the Gore Viabahn and Hemobahn stent grafts. NovoStent recently raised $3.1 mil. for its first human trial evaluating its self-expanding helical stent in the superficial femoral artery, scheduled to start in 2006 (1"The Gray Sheet" Sept. 5, 2005, p. 14)...

People In Brief

NovoStent gets new CEO: Ray Martin, PhD, will replace the firm's founder and primary inventor, Michael Hogendijk, as President & CEO. Hogendijk will continue as chief technical officer. Martin was most recently VP-business development of TriVascular, which was acquired by Boston Scientific in April. He also has held executive positions at Bard and W.L. Gore, where he co-invented the Gore Viabahn and Hemobahn stent grafts. NovoStent recently raised $3.1 mil. for its first human trial evaluating its self-expanding helical stent in the superficial femoral artery, scheduled to start in 2006 (1"The Gray Sheet" Sept. 5, 2005, p. 14)...

Greatbatch CFO search

Firm will conduct a nationwide search following the June 13 departure of Chief Financial Officer Lawrence Reinhold. The medical device battery company credits Reinhold with building the firm's IT organization. Reinhold's departure follows President Thomas Hook's promotion from COO (1"The Gray Sheet" June 13, 2005, p. 8)...

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT022247

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel